Boen L. Kam

Radiolabeled Somatostatin Analog [¹⁷⁷Lu-DOTA⁰,Tyr³]Octreotate in Patients With Endocrine Gastroenteropancreatic Tumors

Dik J. Kwekkeboom, Jaap J.M. Teunissen, Willem H. Bakker et al. · Journal of Clinical Oncology · 2005 · 659 citations · Full text

Medicine, Oncology, Pharmacology +15

Persistent Hematologic Dysfunction after Peptide Receptor Radionuclide Therapy with ¹⁷⁷Lu-DOTATATE: Incidence, Course, and Predicting Factors in Patients with Gastroenteropancreatic Neuroendocrine Tumors

Hendrik Bergsma, Kirsten van Lom, Marc H.G.P. Raaijmakers et al. · Journal of Nuclear Medicine · 2017 · 135 citations

Medicine, Hematology, Oncology +17

Neoadjuvant Treatment of Nonfunctioning Pancreatic Neuroendocrine Tumors with [ ¹⁷⁷ Lu-DOTA ⁰ ,Tyr ³ ]Octreotate

Esther I. van Vliet, Casper H.J. van Eijck, Ronald R. de Krijger et al. · Journal of Nuclear Medicine · 2015 · 122 citations · Full text

Medicine, Oncology, Surgery +17